Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02039856 · ClinicalTrials.gov registry record · NA
Implementation of Women's Health Patient Aligned Care Teams
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 3,900
- Enrollment target
NCT02039856: Completed NA study, sponsored by VA Office of Research and Development.
NCT02039856 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 3,900 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (178% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02039856, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,900 participants
- Enrollment target
Study Summary
VA has undertaken a major initiative to transform care through implementation of Patient Aligned Care Teams (PACTs). Based on the patient-centered medical home (PCMH) concept, PACT aims to improve access, continuity, coordination and comprehensiveness using team-based care that is patient-driven and patient-centered. However, how VA should adapt PACT to meet the needs of special populations, such as women Veterans, is yet to be worked out. The main goal of this study was to develop and test an evidence-based quality improvement (EBQI) approach to adapting and implementing PACT for women Veterans, incorporating comprehensive women's health care in gender-sensitive care environments, thereby accelerating achievement of PACT tenets for women Veterans and reducing persistent gender disparities in VA quality of care.
Primary Outcome
The Women's Health Patient-Aligned Care Team achievement, based on four patient-reported measures of access to care, patient-provider communication, comprehensiveness of care, and gender-appropriateness of care. The WH-PACT achievement is an aggregate score from -4 to +4, with the higher score meaning better PACT achievement.
Interventions
- OTHER Technical support
- OTHER Multilevel stakeholder engagement
- OTHER Quality improvement (QI) education/training
- OTHER Formative feedback
- OTHER External practice facilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,900 participants |
| Start Date | 2014-05-09 |
| Est. Completion | 2018-09-30 |
| Phase | NA |
What the finished NCT02039856 record still lists
NCT02039856 is an interventional study that assigns participants to a tested intervention. Its 3,900 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (178% higher).
The record links to 0 conditions, and to 5 interventions - of which Technical support is the first listed.
NCT02039856 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02039856 about?
NCT02039856 is a clinical study titled "Implementation of Women's Health Patient Aligned Care Teams". VA has undertaken a major initiative to transform care through implementation of Patient Aligned Care Teams (PACTs). Based on the patient-centered medical home (PCMH) concept, PACT aims to improve access, continuity, coordination and comprehensiveness using team-based care that is patient-driven and...
What is the current status of trial NCT02039856?
This trial is currently completed. It is a NA study. The enrollment target is 3,900 participants. The study started on 2014-05-09. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT02039856?
The interventions under investigation include: Technical support (OTHER), Multilevel stakeholder engagement (OTHER), Quality improvement (QI) education/training (OTHER), Formative feedback (OTHER), External practice facilitation (OTHER).
Who is sponsoring clinical trial NCT02039856?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02039856's enrollment target sits among peer trials
3,900 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05919342 · 3,904 participants · NA
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
- NCT03936335 · 3,930 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT05879926 · 3,960 participants · Phase 3
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI